Announcement & Circular_Prospectus_Beijing Yongtai Biological Products Co., Ltd.

永泰生物

Home

About

Science and products

Patient area

News

Investor Relations

Research cooperation

Careers

Contact

YONGTAI

Website construction: China Enterprise Power京ICP备19008112号 PowerBy:300.cn Beijing

yongtai

Investor Relations

Monthly

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

PROPOSED

PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE FOURTH MEMORANDUM AND ARTICLES OF ASSOCIATION

ANNOUNCEMENT

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023

Date

Date of Board Meeting

Monthly

Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

THE

THE CLINICAL TRIAL APPROVAL FOR THE aT19 INJECTION

Notification

Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Notification

Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Monthly

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

FIRST

FIRST PATIENT ENROLLED IN THE PHASE II CLINICAL TRIAL FOR CAR-T-19 INJECTION

Monthly

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Monthly

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023